How many insider trades does FilingIQ track for BBNX?

FilingIQ tracks 106 Form 4 insider transactions for BBNX (Beta Bionics, Inc.), covering filings from Jan 31, 2025 onwards. 21 of those were filed in the last 90 days.

Are BBNX insiders net buyers or net sellers?

Across the full Form 4 history for BBNX, 2 transactions (2%) were open-market purchases and 55 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BBNX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is BBNX in?

Beta Bionics, Inc. (BBNX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $513.50M.

BBNX insider trading

NasdaqGM Healthcare

Beta Bionics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

106

Last 90 days

Buys / sells

2% / 52%

Market cap

$513.50M

About Beta Bionics, Inc.

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California.

Company website: www.betabionics.com

BBNX insider activity at a glance

FilingIQ has scored 106 insider transactions for BBNX since Jan 31, 2025. The most recent filing in our index is dated Mar 4, 2026.

Across the full history, 2 open-market purchases and 55 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BBNX insider trades is 55.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live BBNX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for BBNX?: FilingIQ tracks 106 Form 4 insider transactions for BBNX (Beta Bionics, Inc.), covering filings from Jan 31, 2025 onwards. 21 of those were filed in the last 90 days.
Are BBNX insiders net buyers or net sellers?: Across the full Form 4 history for BBNX, 2 transactions (2%) were open-market purchases and 55 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BBNX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BBNX in?: Beta Bionics, Inc. (BBNX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $513.50M.

Methodology & sources

Every BBNX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.